PFE vs UPS: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and United Parcel Service, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
VS
United Parcel Service, Inc. · Industrials
$105.00
+12.9% upside to fair value
Grade B
QuantHub Verdict
UPS has more upside to fair value (+12.9%). UPS trades at a lower forward P/E (17.0x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric PFE UPS
Current Price $25.22 $105.00
Fair Value Estimate $25.92 $118.53
Upside to Fair Value +2.8% +12.9%
Market Cap $143.7B $89.2B
Forward P/E 19.2x 17.0x
EV / EBITDA 12.3x 9.6x
Price / Sales 2.3x 1.0x
Price / FCF 15.2x 19.8x
Revenue Growth YoY +5.4% -1.6%
Gross Margin 69.3% 17.8%
Operating Margin 23.4% 8.5%
Return on Equity 8.4% 33.0%
Dividend Yield 0% 0%
FCF Yield 6.6% 5.06%
Analyst Consensus Hold Buy
Investment Thesis
PFE — Pfizer Inc.
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
UPS — United Parcel Service, Inc.
United Parcel Service, Inc. operates as a global integrated freight and logistics company with a strong presence in U.S. domestic package delivery, international package services, and supply chain solutions. The company benefits from a durable competitive moat supported by its extensive network capabilities, premium service positioning, and strategic focus on higher-margin segments such as health…
Accumulation Zones
Metric PFE UPS
Zone Low $19.44 $88.90
Zone High $22.03 $100.75
In Buy Zone? No No
← PFE Research    UPS Research →    All Research